BR100 Decreased By (-1.39%)
BR30 Decreased By (-1.72%)
KSE100 Decreased By (-1.3%)
KSE30 Decreased By (-1.25%)
AGHA 7.92 Decreased By ▼ -0.17 (-2.1%)
BECO 5.20 Decreased By ▼ -0.07 (-1.33%)
BML 59.25 Decreased By ▼ -0.13 (-0.22%)
BOP 33.68 Decreased By ▼ -0.51 (-1.49%)
CNERGY 9.81 Increased By ▲ 0.19 (1.98%)
CSIL 5.42 Decreased By ▼ -0.08 (-1.45%)
FCCL 53.52 Decreased By ▼ -0.63 (-1.16%)
FFL 16.68 Decreased By ▼ -0.16 (-0.95%)
FNEL 1.21 Decreased By ▼ -0.02 (-1.63%)
KEL 7.35 Decreased By ▼ -0.24 (-3.16%)
KOSM 5.61 Decreased By ▼ -0.07 (-1.23%)
LOTCHEM 29.11 Decreased By ▼ -1.32 (-4.34%)
MLCF 95.50 Decreased By ▼ -2.66 (-2.71%)
NBP 204.35 Decreased By ▼ -4.44 (-2.13%)
NCPL 58.24 Decreased By ▼ -1.37 (-2.3%)
NPL 67.79 Decreased By ▼ -2.08 (-2.98%)
OGDC 317.94 Decreased By ▼ -5.42 (-1.68%)
PACE 10.71 Decreased By ▼ -0.36 (-3.25%)
PAEL 41.83 Decreased By ▼ -0.42 (-0.99%)
PIBTL 16.50 Decreased By ▼ -0.32 (-1.9%)
PPL 219.74 Decreased By ▼ -4.99 (-2.22%)
PRL 44.59 Increased By ▲ 2.94 (7.06%)
PTC 70.77 Decreased By ▼ -0.35 (-0.49%)
SSGC 28.93 Decreased By ▼ -0.38 (-1.3%)
TBL 9.84 Decreased By ▼ -0.12 (-1.2%)
TELE 8.76 Decreased By ▼ -0.23 (-2.56%)
TPL 16.45 Decreased By ▼ -0.07 (-0.42%)
TPLP 12.10 Decreased By ▼ -0.67 (-5.25%)
TREET 22.80 Decreased By ▼ -0.26 (-1.13%)
TRG 60.03 Decreased By ▼ -0.42 (-0.69%)
By

FRANKFURT: European shares were subdued on Monday, ahead of key meetings between Ukraine, European leaders and US President Donald Trump, following a Russia-US summit that ended without an immediate agreement.

The pan-European STOXX 600 index closed 0.1% up, after logging a second straight weekly gain on Friday.

Ukraine’s Volodymyr Zelenskiy will meet Trump along with other European leaders in a bid to draw out a peace deal that will not favour Moscow.

Trump met with his Russian counterpart Vladimir Putin on Friday and agreed that a peace deal should be worked upon without a ceasefire.

Europe’s index tracking aerospace and defence stocks was up 0.7%, after falling in the last session. UK’s Babcock gained 5.2% after RBC initiated the engineering company at “Outperform”.

“If we can get to a peace agreement, the market would likely take that positively, but it remains unclear at this stage, given that the two sides seem quite far apart,” said Kiran Ganesh, multi-asset strategist at UBS Global Wealth Management.

“We don’t have a lot of clarity on how they (important market catalysts) might turn out, so the market has been quite directionless.”

Most sectors on the benchmark STOXX 600 were lower, with a 1.6% and 0.5% decline in miners and heavyweight banks weighing the most.

Novo Nordisk jumped 6.6% after the drugmaker’s weight-loss drug Wegovy received an accelerated approval by the US Food and Drug Administration to treat a serious liver condition.

Separately, it announced it was offering its diabetes drug Ozempic for $499 per month to eligible patients in the US

The gains boosted the healthcare sector up 1.4%, logging its eighth session of gains. The sector took a beating this year, on uncertainty around Trump’s pharma tariffs, but is making a recovery.

Most regional bourses also closed lower, while UK’s FTSE 100 managed to eke out a 0.2% gain.

The Federal Reserve’s annual Jackson Hole symposium later this week will be in focus, where Chair Jerome Powell and other policymakers will talk economic outlook and the central bank’s policy framework.

Comments

Comments are closed for this article.